| North Texas Foot Ankle | |
|
1145 Kinwest Pkwy, Suite 100, Irving, TX 75063-3409 | |
| (214) 574-9255 | |
| (214) 574-9258 |
| Full Name | North Texas Foot Ankle |
|---|---|
| Type | Facility |
| Speciality | Podiatrist - Foot & Ankle Surgery |
| Location | 1145 Kinwest Pkwy, Irving, Texas |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1588706964 | NPI | - | NPPES |
| 0033NV | Other | TX | BCBS GROUP |
| 1821074451 | Other | TX | DR HOLCOMBE NPI |
| 00Y157 | Other | TX | MEDICARE GRP NUMBER |
| 1588706964 | Other | TX | GRP NPI |
| 101253500 | Other | TX | WORKERS COMP NUMBER |
| 1538187067 | Other | TX | DR. CHENG NPI |
| 7061140 | Other | TX | AETNA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213ES0103X | Podiatrist - Foot & Ankle Surgery | 1490 (Texas) | Primary |
| Provider Name | Ronica Holcombe |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1821074451 PECOS PAC ID: 6103737440 Enrollment ID: I20050329001069 |
News Archive
NexMed, Inc., a specialty CRO with a pipeline of products based on the NexACT® technology, today announced results from a pre-clinical study showing that calcipotriene 0.005% and betamethasone dipropionate 0.064%, when formulated with NexACT®, results in a topical treatment which shows bioequivalecy in efficacy to Talconex®, one of the leading topical treatments marketed for patients with mild to moderate psoriasis.
When Speaker Nancy Pelosi unveiled the revised House Democratic health care bill last week, the Obama White House hailed it as a "critical milestone" in the process. No doubt senior administration officials were relieved to see signs of "momentum" toward passage of something. But if the president really meant what he has said about health care policy throughout this year, his administration would be working to defeat the Pelosi bill, not supporting it (James Capretta).
During his State of the Union address, President Barack Obama renewed a proposal to use drug rebates to save Medicare money - a step that would trigger strong opposition from pharmaceutical companies.
In new findings that could have an impact the development of therapies for a number of currently untreatable brain disorders such as Parkinson's and Huntington's diseases, scientists from the Florida campus of The Scripps Research Institute (TSRI) have found, for the first time, that a specific signaling circuit in the brain is deeply involved in motor activity.
A new study by researchers from the Medical College of Wisconsin, in Milwaukee, found a substantial variation in hydroxyurea utilization for pain and other sickle cell disease complications in children.
› Verified 4 days ago
| Provider Name | Todd George Lewis |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1184802910 PECOS PAC ID: 3375771892 Enrollment ID: I20170519002233 |
News Archive
NexMed, Inc., a specialty CRO with a pipeline of products based on the NexACT® technology, today announced results from a pre-clinical study showing that calcipotriene 0.005% and betamethasone dipropionate 0.064%, when formulated with NexACT®, results in a topical treatment which shows bioequivalecy in efficacy to Talconex®, one of the leading topical treatments marketed for patients with mild to moderate psoriasis.
When Speaker Nancy Pelosi unveiled the revised House Democratic health care bill last week, the Obama White House hailed it as a "critical milestone" in the process. No doubt senior administration officials were relieved to see signs of "momentum" toward passage of something. But if the president really meant what he has said about health care policy throughout this year, his administration would be working to defeat the Pelosi bill, not supporting it (James Capretta).
During his State of the Union address, President Barack Obama renewed a proposal to use drug rebates to save Medicare money - a step that would trigger strong opposition from pharmaceutical companies.
In new findings that could have an impact the development of therapies for a number of currently untreatable brain disorders such as Parkinson's and Huntington's diseases, scientists from the Florida campus of The Scripps Research Institute (TSRI) have found, for the first time, that a specific signaling circuit in the brain is deeply involved in motor activity.
A new study by researchers from the Medical College of Wisconsin, in Milwaukee, found a substantial variation in hydroxyurea utilization for pain and other sickle cell disease complications in children.
› Verified 4 days ago
| Provider Name | Kyle J Duncan |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1598185712 PECOS PAC ID: 4688948219 Enrollment ID: I20170921000056 |
News Archive
NexMed, Inc., a specialty CRO with a pipeline of products based on the NexACT® technology, today announced results from a pre-clinical study showing that calcipotriene 0.005% and betamethasone dipropionate 0.064%, when formulated with NexACT®, results in a topical treatment which shows bioequivalecy in efficacy to Talconex®, one of the leading topical treatments marketed for patients with mild to moderate psoriasis.
When Speaker Nancy Pelosi unveiled the revised House Democratic health care bill last week, the Obama White House hailed it as a "critical milestone" in the process. No doubt senior administration officials were relieved to see signs of "momentum" toward passage of something. But if the president really meant what he has said about health care policy throughout this year, his administration would be working to defeat the Pelosi bill, not supporting it (James Capretta).
During his State of the Union address, President Barack Obama renewed a proposal to use drug rebates to save Medicare money - a step that would trigger strong opposition from pharmaceutical companies.
In new findings that could have an impact the development of therapies for a number of currently untreatable brain disorders such as Parkinson's and Huntington's diseases, scientists from the Florida campus of The Scripps Research Institute (TSRI) have found, for the first time, that a specific signaling circuit in the brain is deeply involved in motor activity.
A new study by researchers from the Medical College of Wisconsin, in Milwaukee, found a substantial variation in hydroxyurea utilization for pain and other sickle cell disease complications in children.
› Verified 4 days ago
| Provider Name | Sara Millar |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1194254193 PECOS PAC ID: 5193149664 Enrollment ID: I20200717000576 |
News Archive
NexMed, Inc., a specialty CRO with a pipeline of products based on the NexACT® technology, today announced results from a pre-clinical study showing that calcipotriene 0.005% and betamethasone dipropionate 0.064%, when formulated with NexACT®, results in a topical treatment which shows bioequivalecy in efficacy to Talconex®, one of the leading topical treatments marketed for patients with mild to moderate psoriasis.
When Speaker Nancy Pelosi unveiled the revised House Democratic health care bill last week, the Obama White House hailed it as a "critical milestone" in the process. No doubt senior administration officials were relieved to see signs of "momentum" toward passage of something. But if the president really meant what he has said about health care policy throughout this year, his administration would be working to defeat the Pelosi bill, not supporting it (James Capretta).
During his State of the Union address, President Barack Obama renewed a proposal to use drug rebates to save Medicare money - a step that would trigger strong opposition from pharmaceutical companies.
In new findings that could have an impact the development of therapies for a number of currently untreatable brain disorders such as Parkinson's and Huntington's diseases, scientists from the Florida campus of The Scripps Research Institute (TSRI) have found, for the first time, that a specific signaling circuit in the brain is deeply involved in motor activity.
A new study by researchers from the Medical College of Wisconsin, in Milwaukee, found a substantial variation in hydroxyurea utilization for pain and other sickle cell disease complications in children.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| North Texas Foot Ankle 1145 Kinwest Pkwy, Suite 100, Irving, TX 75063-3409 Ph: (214) 574-9255 | North Texas Foot Ankle 1145 Kinwest Pkwy, Suite 100, Irving, TX 75063-3409 Ph: (214) 574-9255 |
News Archive
NexMed, Inc., a specialty CRO with a pipeline of products based on the NexACT® technology, today announced results from a pre-clinical study showing that calcipotriene 0.005% and betamethasone dipropionate 0.064%, when formulated with NexACT®, results in a topical treatment which shows bioequivalecy in efficacy to Talconex®, one of the leading topical treatments marketed for patients with mild to moderate psoriasis.
When Speaker Nancy Pelosi unveiled the revised House Democratic health care bill last week, the Obama White House hailed it as a "critical milestone" in the process. No doubt senior administration officials were relieved to see signs of "momentum" toward passage of something. But if the president really meant what he has said about health care policy throughout this year, his administration would be working to defeat the Pelosi bill, not supporting it (James Capretta).
During his State of the Union address, President Barack Obama renewed a proposal to use drug rebates to save Medicare money - a step that would trigger strong opposition from pharmaceutical companies.
In new findings that could have an impact the development of therapies for a number of currently untreatable brain disorders such as Parkinson's and Huntington's diseases, scientists from the Florida campus of The Scripps Research Institute (TSRI) have found, for the first time, that a specific signaling circuit in the brain is deeply involved in motor activity.
A new study by researchers from the Medical College of Wisconsin, in Milwaukee, found a substantial variation in hydroxyurea utilization for pain and other sickle cell disease complications in children.
› Verified 4 days ago
Kent Olsen, DPM Podiatrist Medicare: Medicare Enrolled Practice Location: 2001 N Macarthur Blvd Ste 300, Irving, TX 75061 Phone: 972-254-0680 Fax: 972-254-0683 | |
Divine Footcare Center Inc Podiatrist Medicare: Medicare Enrolled Practice Location: 2000 Esters Rd Ste 104, Suite 104, Irving, TX 75061 Phone: 972-790-2800 Fax: 972-790-2803 | |
Southwest Podiatry, Llp Podiatrist Medicare: Medicare Enrolled Practice Location: 2001 N Macarthur Blvd Ste 300, Irving, TX 75061 Phone: 972-254-0680 Fax: 972-254-0683 | |
Larissa Rolim, DPM, MS Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1440 N Macarthur Blvd Ste 101, Irving, TX 75061 Phone: 469-777-4078 Fax: 469-777-4051 | |
Todd George Lewis, D.P.M Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1145 Kinwest Pkwy Ste 100, Irving, TX 75063 Phone: 214-574-9255 | |
Maverick Foot And Ankle Specialists Pllc Podiatrist Medicare: Medicare Enrolled Practice Location: 1440 N Macarthur Blvd Ste 101, Irving, TX 75061 Phone: 305-332-1672 | |
Dr. Alex W Garcia, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 800 W. Airport Freeway, Suite 110, Irving, TX 75062 Phone: 214-492-1970 Fax: 214-441-3039 |